The treatment journeyNovember 18, 2026

Changing medication or route: a clinician conversation guide

Changing from one medicine to another, or from injection to tablet, is a decision for you and your prescriber. Different products have different labels, studies and instructions, and results do not carry over automatically. The Wegovy label has a section on switching between its injection and tablets that is written for prescribers. This page gives no switching schedule, and does not recommend a change.

Sources checked against Europe PMC abstracts and FDA/DailyMed label text: Nov 17, 2026; full text not read for abstract-only claims (recheck on publication date)

Quick answer

Changing from one medicine to another, or from injection to tablet, is a decision for you and your prescriber. Different products have different labels, studies and instructions, and results do not carry over automatically. The Wegovy label has a section on switching between its injection and tablets that is written for prescribers. This page gives no switching schedule, and does not recommend a change.

Why a switch needs a prescriber

  • Different products and forms have their own labels. Dosing, missed-dose rules and storage differ. See the articles on missed doses and on storing your medication.
  • Evidence is product-specific. The Wegovy tablet label reports one trial of 204 adults with obesity or overweight (up to 64 weeks) in which 6.9% of people on the 25 mg tablet and 5.9% on placebo stopped because of adverse reactions, and 3.4% versus 2% stopped because of digestive reactions. Source: Wegovy label, section 6.1.

Wegovy tablet trial

Wegovy tablet trial

  • Labels address switching directly. The Wegovy label has a “Switching Between WEGOVY Injection and WEGOVY Tablets” section for prescribers that sets out how the change is made. Source: Wegovy label, section 2.5. This page does not repeat it, because it depends on your product and plan.

Reasons people raise a change

Side effects, cost or coverage, supply, convenience, or results that did not meet goals. Name your reason; it shapes the options. See the articles on prior authorization and on supply gaps.

A conversation guide

  • What is my reason for changing, and what else could address it?
  • What does the label for the new product say about starting, missed doses and storage?
  • What follow-up will we do, and what should I track?
  • What is the cost and coverage for each option?
  • What should I watch for, and who do I call?

What to bring

Your current product, strength and form; the date of your last dose; side effects you have had; any problems with coverage or supply; and your questions.

What this does not establish

One trial’s discontinuation rates do not predict your experience or compare forms. This page does not say whether any switch is appropriate.

FAQs

What should I discuss with my clinician about changing medication or route? Your reason, the options, the new product’s label, follow-up and cost.

What information should I track or bring? Your product, dose dates, side effects and coverage details.

Where can I find the instructions for my exact medicine? The Medication Guide and prescribing information.

Sources

  1. Wegovy prescribing information, FDA
  2. Wegovy Medication Guide, DailyMed